Toagosei (4045) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
6 Nov, 2026Executive summary
3Q FY2026 net sales rose 8.9% YoY to ¥43,055m and operating income rose 8.0% to ¥3,874m; net income attributable to owners of parent increased 27.1% to ¥2,907m.
Nine-month net sales grew 4.7% to ¥125,461m, operating income rose 11.1% to ¥11,787m, and net income attributable to owners of parent increased 11.6% to ¥8,927m.
Financial highlights
Nine-month ordinary profit rose 8.5% to ¥12,098m; basic EPS was ¥84.05 versus ¥72.99.
3Q ordinary profit declined 3.7% YoY to ¥3,518m, despite higher sales and operating income.
Nine-month operating income increased ¥1.18bn; volume contributed ¥4.4bn, offset by unit-price impact of ¥2.4bn and fixed-cost impact of ¥0.9bn.
Nine-month comprehensive income increased 54.7% YoY to ¥14,769m.
Segment performance
Commodity Chemicals nine-month sales fell ¥1,195m to ¥52,144m and operating income declined ¥1,705m to ¥5,025m.
Polymer & Oligomer sales rose ¥3,305m to ¥29,907m and operating income increased ¥1,341m to ¥3,550m; demand grew in mobility, pharma, cosmetics, semiconductor and electronic-material applications.
Adhesive Material sales grew ¥975m to ¥11,026m and operating income rose ¥206m to ¥422m, supported by mobility- and smartphone-related volumes and U.S. price revisions.
Performance Chemicals sales increased ¥1,229m to ¥8,661m and operating income rose ¥679m to ¥1,420m, supported by semiconductor demand and high-purity inorganic chemical volumes.
Plastics sales increased ¥1,346m to ¥22,042m and operating income rose ¥930m to ¥2,906m; infrastructure-related and Southeast Asian sales expanded.
Latest events from Toagosei
- Sales and operating income rose, with a higher dividend forecast and net income set to decline.4045
Q2 2026 - Net income rose 38.7% despite a 3.0% sales drop, driven by extraordinary gains.4045
Q1 2026 - Strong 1H FY2024 growth drives higher full-year forecasts and increased shareholder returns.4045
Q2 2024 - Strong sales, profit, and EPS growth with robust 2024 guidance and stable dividend.4045
Q3 2024 - FY2024 saw higher sales, profits, and dividends, with FY2025 targeting further profit growth.4045
Q4 2024 - Sales and profits fell, outlook was lowered, and U.S. adhesives business was restructured.4045
Q2 2025 - Net sales rose 2.1% year-over-year, but profits fell and dividend forecast increased amid uncertainty.4045
Q1 2025 - Net sales fell but net income rose on asset sales; FY2026 targets modest growth and strong returns.4045
Q4 2025 - Net sales and profits fell year-over-year, but the dividend payout is set to rise.4045
Q3 2025